Evidence map›Paper›PMID 30232539›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2019

Mike Sathekge, Frank Bruchertseifer, Otto Knoesen, Florette Reyneke, Ismaheel Lawal, Thabo Lengana, Cindy Davis, Johncy Mahapane, Ceceila Corbett, Mariza Vorster and 1 more

Erratum issuedOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 169 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed, 9 pooled it
32.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 9 syntheses or guidelines pooled it, 338 citations in OpenAlex.

  1. Beyond [BMC cancer · 2026
    Pooled it
  2. Evaluating Xerostomia as a side effect of [European journal of nuclear medicine and molecular imaging · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Efficacy and Safety of Actinium-225 Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Prostate Cancer: A Systematic Review and Metanalysis.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2023
    Pooled it
  6. Efficacy and Safety ofFrontiers in oncology · 2022
    Pooled it
  7. Evolving role ofProstate cancer and prostatic diseases · 2021
    Pooled it
  8. Pooled it
  9. Pooled it
  10. The Impact of Monosodium Glutamate onJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Trial
  11. Trial
  12. Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer withJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Trial
  13. Observational
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Compton Imaging of Ac-225 In Pre-clinical Phantoms With a 3D-positioning CZT Camera.IEEE transactions on radiation and plasma medical sciences · 2026
    Article

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Mike SathekgeDepartment of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa. mike.sathekge@up.ac.za.ORCID http://orcid.org/0000-0002-2806-0625
Frank BruchertseiferEuropean Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.
Otto KnoesenNuclear Technology Products (NTP), Pelindaba, South Africa.
Florette ReynekeDepartment of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa.
Ismaheel LawalDepartment of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa.
Thabo LenganaDepartment of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa.
Cindy DavisDepartment of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa.
Johncy MahapaneDepartment of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa.
Ceceila CorbettDepartment of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa.
Mariza VorsterDepartment of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa.
Alfred MorgensternDepartment of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa.
Steve Biko Hospital · ZAJoint Research Centre · DESouth African Nuclear Energy Corporation (South Africa) · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA remarkable therapeutic efficacy has been demonstrated with

methodsSeventeen patients with advanced prostate cancer were selected for treatment with

resultsGood antitumor activity assessed by serum PSA level and

conclusions

Indexed as

ActiniumAgedAged, 80 and overCarcinomaDipeptidesEdetic AcidGallium IsotopesGallium RadioisotopesHeterocyclic Compounds, 1-RingHumansMaleMiddle AgedOligopeptidesPilot ProjectsPositron Emission Tomography Computed TomographyProstate-Specific Antigen(225)Ac-PSMA-617ActiniumActinium-225DipeptidesEdetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesHeterocyclic Compounds, 1-RingOligopeptidesProstate-Specific AntigenPSMA-617RadiopharmaceuticalsActinium-225Chemotherapy-naïveProstate cancerPSA responsePSMARadioligand therapy

Identifiers

PMID30232539
PMCPMC6267694
OpenAlexW2889801464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.